Breast Cancer Type: Triple Negative
Breast Cancer Tissue:
Recruitment Status: Recruiting
Drug Category: Serine-Threonine Kinase Inhibitor, Misc Inhibitor, Immunotherapy, Therapeutic Antibody
Key Eligibility Criteria:
Age: 18 Years and older (Adult, Senior)
Location of Metastases:
Exclusions: Presence of symptomatic central nervous system (CNS) metastases, or CNS metastases that require local CNS-directed therapy within prior 2 weeks.